BRM/BRG1 ATP Inhibitor-2

CAS No. 2368900-77-8

BRM/BRG1 ATP Inhibitor-2( —— )

Catalog No. M28502 CAS No. 2368900-77-8

BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 147 In Stock
5MG 132 In Stock
10MG 211 In Stock
25MG 425 In Stock
50MG 613 In Stock
100MG 873 In Stock
200MG Get Quote In Stock
500MG 1748 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRM/BRG1 ATP Inhibitor-2
  • Note
    Research use only, not for human use.
  • Brief Description
    BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
  • Description
    BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2368900-77-8
  • Formula Weight
    412.53
  • Molecular Formula
    C20H20N4O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (242.41 mM)
  • SMILES
    CSCC[C@H](NC(C1=CN=CC=C1)=O)C(NC2=NC(C3=CC=CC=C3)=CS2)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Y06137

    Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.

  • PBRM1-BD2-IN-2

    PBRM1-BD2-IN-2, a selective and cell-active inhibitor of the polybromo-1 (PBRM1) bromodomain, exhibits binding affinity and inhibitory activity specifically targeting the PBRM1-BD2 domain, with Kd and IC50 values of 9.3 μM and 1.0 μM, respectively.

  • GSK778 hydrochloride

    GSK778 hydrochloride hydrochloride is a potent and selective BD1 bromodomain inhibitor of the BET proteins, with IC50s of 75 nM (BRD2 BD1), 41 nM (BRD3 BD1), 41 nM (BRD4 BD1), and 143 nM (BRDT BD1), respectively.